These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 23831611)
1. Development of an ELISA for the quantification of the C-terminal decapeptide prothymosin α(100-109) in sera of mice infected with bacteria. Samara P; Kalbacher H; Ioannou K; Radu DL; Livaniou E; Promponas VJ; Voelter W; Tsitsilonis O J Immunol Methods; 2013 Sep; 395(1-2):54-62. PubMed ID: 23831611 [TBL] [Abstract][Full Text] [Related]
2. Development and immunochemical evaluation of antibodies Y for the poorly immunogenic polypeptide prothymosin alpha. Klimentzou P; Paravatou-Petsotas M; Zikos C; Beck A; Skopeliti M; Czarnecki J; Tsitsilonis O; Voelter W; Livaniou E; Evangelatos GP Peptides; 2006 Jan; 27(1):183-93. PubMed ID: 16150512 [TBL] [Abstract][Full Text] [Related]
3. The immunologically active site of prothymosin alpha is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients. Skopeliti M; Voutsas IF; Klimentzou P; Tsiatas ML; Beck A; Bamias A; Moraki M; Livaniou E; Neagu M; Voelter W; Tsitsilonis OE Cancer Immunol Immunother; 2006 Oct; 55(10):1247-57. PubMed ID: 16453152 [TBL] [Abstract][Full Text] [Related]
4. A fragment of the alarmin prothymosin α as a novel biomarker in murine models of bacteria-induced sepsis. Samara P; Miriagou V; Zachariadis M; Mavrofrydi O; Promponas VJ; Dedos SG; Papazafiri P; Kalbacher H; Voelter W; Tsitsilonis O Oncotarget; 2017 Jul; 8(30):48635-48649. PubMed ID: 28611290 [TBL] [Abstract][Full Text] [Related]
6. Specific in vitro binding of a new (99m)Tc-radiolabeled derivative of the C-terminal decapeptide of prothymosin alpha on human neutrophils. Karachaliou CE; Liolios C; Triantis C; Zikos C; Samara P; Tsitsilonis OE; Kalbacher H; Voelter W; Papadopoulos M; Pirmettis I; Livaniou E Int J Pharm; 2015; 486(1-2):1-12. PubMed ID: 25796124 [TBL] [Abstract][Full Text] [Related]
7. Immunocytological and preliminary immunohistochemical studies of prothymosin alpha, a human cancer-associated polypeptide, with a well-characterized polyclonal antibody. Klimentzou P; Drougou A; Fehrenbacher B; Schaller M; Voelter W; Barbatis C; Paravatou-Petsotas M; Livaniou E J Histochem Cytochem; 2008 Nov; 56(11):1023-31. PubMed ID: 18711212 [TBL] [Abstract][Full Text] [Related]
8. Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice. Voutsas IF; Pistamaltzian N; Tsiatas ML; Skopeliti M; Katsila T; Mavrothalassiti I; Spyrou S; Dimopoulos MA; Tsitsilonis OE; Bamias A Eur J Cancer; 2013 May; 49(7):1706-14. PubMed ID: 23276721 [TBL] [Abstract][Full Text] [Related]
11. [Prothymosin alpha and tumor: current status and perspective]. Wang M; Pan JY Ai Zheng; 2007 Mar; 26(3):333-6. PubMed ID: 17355803 [TBL] [Abstract][Full Text] [Related]
12. The C-terminal decapeptide of prothymosin α is responsible for its stimulatory effect on the functions of human neutrophils in vitro. Samara P; Ioannou K; Neagu M; Arnogiannaki N; Ardavanis A; Voelter W; Tsitsilonis O Int Immunopharmacol; 2013 Jan; 15(1):50-7. PubMed ID: 23201434 [TBL] [Abstract][Full Text] [Related]
13. In vivo biodistribution and imaging studies with a Karachaliou CE; Triantis C; Liolios C; Palamaris L; Zikos C; Tsitsilonis OE; Kalbacher H; Voelter W; Loudos G; Papadopoulos M; Pirmettis I; Livaniou E Eur J Pharm Biopharm; 2017 Apr; 113():188-197. PubMed ID: 28087377 [TBL] [Abstract][Full Text] [Related]
14. Development of ELISA to estimate thymosin alpha1, the N terminus of prothymosin alpha, in human tumors. Loidi L; Vidal A; Zalvide JB; Puente JL; Reyes F; Domínguez F Clin Chem; 1997 Jan; 43(1):59-63. PubMed ID: 8990223 [TBL] [Abstract][Full Text] [Related]
15. Stress-induced non-vesicular release of prothymosin-α initiated by an interaction with S100A13, and its blockade by caspase-3 cleavage. Matsunaga H; Ueda H Cell Death Differ; 2010 Nov; 17(11):1760-72. PubMed ID: 20467443 [TBL] [Abstract][Full Text] [Related]
16. Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications? Samara P; Ioannou K; Tsitsilonis OE Vitam Horm; 2016; 102():179-207. PubMed ID: 27450735 [TBL] [Abstract][Full Text] [Related]
17. Characterization of two thymosins as immune-related genes in common carp (Cyprinus carpio L.). Xiao Z; Shen J; Feng H; Liu H; Wang Y; Huang R; Guo Q Dev Comp Immunol; 2015 May; 50(1):29-37. PubMed ID: 25596145 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of prothymosin α leads to apoptosis and developmental defects in zebrafish embryos. Emmanouilidou A; Karetsou Z; Tzima E; Kobayashi T; Papamarcaki T Biochem Cell Biol; 2013 Oct; 91(5):325-32. PubMed ID: 24032683 [TBL] [Abstract][Full Text] [Related]